Tucatinib plus trastuzumab for chemotherapy-refractory, HER2 + , RAS wild-type metastatic colorectal cancer (MOUNTAINEER): final analysis
图卡替尼联合曲妥珠单抗治疗化疗难治性、HER2阳性、RAS野生型转移性结直肠癌（MOUNTAINEER研究）：最终分析
期刊:Nature Communications
影响因子:15.7
doi:10.1038/s41467-025-67824-z
Strickler, John H; Cercek, Andrea; Siena, Salvatore; André, Thierry; Ng, Kimmie; Van Cutsem, Eric; Wu, Christina; Paulson, Andrew Scott; Hubbard, Joleen M; Coveler, Andrew L; Fountzilas, Christos; Kardosh, Adel; Kasi, Pashtoon Murtaza; Lenz, Heinz-Josef; Ciombor, Kristen; Elez, Elena; Bajor, David L; Cremolini, Chiara; Sanchez, Federico; Nayeri, Mina; Feng, Wentao; Bieda, Mark; Bekaii-Saab, Tanios S
